Hotline:
+ 49 (0) 2204 2918806

Market studies for category CNS/Neurology

Items 1 to 10 of 470 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 47
  1. Net price*
    Year
  2. $2,000.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Partial Seizure - Pipeline Review, H1 2015

    Global Markets Direct
    89 pages
    Global Markets Direct’s, ‘Partial Seizure - Pipeline Review, H1 2015’, provides an overview of the Partial Seizure’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Partial Seizure, complete with comparative analysis at various stages, therapeutics assessment by drug target, m
    Englisch | Zukunftsanalyse | SKU: 987688248
  3. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Risperdal (Schizophrenia) - Forecast and Market Analysis to 2022

    GlobalData
    44 pages
    Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms, auditory or visual hallucinations, are often accompanied by fixed, false, and often paranoid beliefs, called delusions. These two features are often combined with learning and cognitive deficits. WHO experts have
    Englisch | Zukunftsanalyse | SKU: 402549
  4. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    CNV-1014802 (Neuropathic Pain) - Forecast and Market Analysis to 2022

    GlobalData
    86 pages
    Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pain. Although the term neuropa
    Englisch | Zukunftsanalyse | SKU: 402963
  5. $2,500.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014

    GlobalData
    54 pages
    GlobalData's clinical trial report, “Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014" provides data on the Dysgeusia (Taste Disorders) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysgeusia (Taste Disorders). It includes an overview of the trial numbe
    Englisch | Zukunftsanalyse | SKU: 403378
  6. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Osteoarthritis Pain - Pipeline Review, H1 2014

    Global Markets Direct
    169 pages
    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2014’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Osteoarthritis Pain, complete with comparative analysis at various stages, therapeutics assessment by dr
    Englisch | Zukunftsanalyse | SKU: 403943
  7. $6,995.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    EpiCast Report: Multiple Sclerosis Epidemiology Forecast to 2022

    GlobalData
    56 pages
    Introduction Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and a wide range of signs and symptoms. MS affects 2.5 million people worldwide each year and is the most debilitating neurological disease in young adults (Fernand
    Englisch | Report | SKU: 329211
  8. $2,500.00
    2015
    Für diese Studie liegt keine Bewertung vor.

    Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2015

    GlobalData
    102 pages
    GlobalData's clinical trial report, “Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Lennox-Gastaut Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lennox-Gastaut Syndrome. It includes an overview of the trial numbers and their
    Englisch | Zukunftsanalyse | SKU: 987678616
  9. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Cerebral Palsy - Pipeline Review, H1 2014

    Global Markets Direct
    63 pages
    Global Markets Direct’s, ‘Cerebral Palsy - Pipeline Review, H1 2014’, provides an overview of the Cerebral Palsy’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Cerebral Palsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mech
    Englisch | Zukunftsanalyse | SKU: 393912
  10. $4,450.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    MediPoint: Neurovascular Interventions - APAC Analysis and Market Forecasts

    GlobalData
    342 pages
    The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions mar
    Englisch | Zukunftsanalyse | SKU: 402774
  11. $3,495.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

    GlobalData
    45 pages
    Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for top selling products,
    Englisch | Zukunftsanalyse | SKU: 403320

Items 1 to 10 of 470 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 47